Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Evaluator Blinded, Randomized Clinical Study to Evaluate the Efficacy and Tolerance of Two Acne Treatment Regimens on Subjects With Mild to Moderate Acne Vulgaris

NCT03124381 is registered in ClinicalTrials.gov with Johnson & Johnson Consumer Inc. (J&JCI) as lead sponsor.

NCT NCT03124381
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03124381 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Evaluator Blinded, Randomized Clinical Study to Evaluate the Efficacy and Tolerance of Two Acne Treatment Regimens on Subjects With Mild to Moderate Acne Vulgaris
Lead sponsor
Johnson & Johnson Consumer Inc. (J&JCI)
Phase
Not applicable
Overall status
Completed
Start date
April 8, 2017
Completion date
September 6, 2017
Enrollment
126 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acne vulgaris